Pathophysiology and Management of Calcium Stones

Urologic Clinics of North America

Volumn 34, Issue 3, 2007, Pages 323-334

  Park, Sangtae ^a   Pearle, Margaret S ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHLORTALIDONE; CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE; INDAPAMIDE; PYRIDOXINE; THIAZIDE DIURETIC AGENT;

CALCIUM STONE; CONSERVATIVE TREATMENT; DIZZINESS; FATIGUE; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; IMPOTENCE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALT INTAKE;

CALCIUM OXALATE; CALCIUM PHOSPHATES; HUMANS; KIDNEY CALCULI;

EID: 34547574015     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2007.04.009     Document Type: Review

References (81)

1. Clark J.Y., Thompson I.M., and Optenberg S.A. Economic impact of urolithiasis in the United States. J Urol 154 6 (1995) 2020-2024
2. Pak C.Y. Kidney stones. Lancet 351 9118 (1998) 1797-1801
3. Preminger G.M. Renal calculi: pathogenesis, diagnosis, and medical therapy. Semin Nephrol 12 2 (1992) 200-216
4. Sierakowski R., Finlayson B., Landes R.R., et al. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 15 6 (1978) 438-441
5. Jungers P., Joly D., Barbey F., et al. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44 5 (2004) 799-805
6. Barcelo P., Wuhl O., Servitge E., et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150 6 (1993) 1761-1764
7. Borghi L., Meschi T., Guerra A., et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22 Suppl 6 (1993) S78-S86
8. Pak C.Y., Poindexter J.R., Adams-Huet B., et al. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115 1 (2003) 26-32
9. Pak C.Y. Etiology and treatment of urolithiasis. Am J Kidney Dis 18 6 (1991) 624-637
10. Mandel N.S., and Mandel G.S. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142 6 (1989) 1516-1521
11. Pearle M.S., Roehrborn C.G., and Pak C.Y. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13 9 (1999) 679-685
12. Kim S.C., Coe F.L., Tinmouth W.W., et al. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol 173 1 (2005) 117-119
13. Kuo R.L., Lingeman J.E., Evan A.P., et al. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int 64 6 (2003) 2150-2154
14. Pak C.Y., Oata M., Lawrence E.C., et al. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest 54 2 (1974) 387-400
15. Coe F.L., Parks J.H., and Moore E.S. Familial idiopathic hypercalciuria. N Engl J Med 300 7 (1979) 337-340
16. Moe O.W., and Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 16 3 (2005) 729-745
17. Pak C.Y., Britton F., Peterson R., et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 69 1 (1980) 19-30
18. Breslau N.A., Preminger G.M., Adams B.V., et al. Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75 6 (1992) 1446-1452
19. Reed B.Y., Gitomer W.L., Heller H.J., et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87 4 (2002) 1476-1485
20. Breslau N.A., McGuire J.L., Zerwekh J.E., et al. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 55 2 (1982) 369-373
21. Cirillo M., Ciacci C., Laurenzi M., et al. Salt intake, urinary sodium, and hypercalciuria. Miner Electrolyte Metab 23 3-6 (1997) 265-268
22. Ruda J.M., Hollenbeak C.S., and Stack Jr. B.C. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132 3 (2005) 359-372
23. Chattopadhyay N. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab 290 5 (2006) E761-E770
24. Bell N.H., Stern P.H., Pantzer E., et al. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64 1 (1979) 218-225
25. Hendrix J.Z. Abnormal skeletal mineral metabolism in sarcoidosis. Ann Intern Med 64 4 (1966) 797-805
26. Adams J.S. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 18 3 (1989) 765-778
27. Hamm L.L., and Hering-Smith K.S. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31 4 (2002) 885-893 viii
28. Pak C.Y. Citrate and renal calculi: an update. Miner Electrolyte Metab 20 6 (1994) 371-377
29. Laing C.M., Toye A.M., Capasso G., et al. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 37 6 (2005) 1151-1161
30. Amanzadeh J., Gitomer W.L., Zerwekh J.E., et al. Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int 64 6 (2003) 2142-2149
31. Reddy S.T., Wang C.Y., Sakhaee K., et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40 2 (2002) 265-274
32. Sakhaee K., Nigam S., Snell P., et al. Assessment of the pathogenetic role of physical exercise in renal stone formation. J Clin Endocrinol Metab 65 5 (1987) 974-979
33. Ravichandran V., and Selvam R. Increased lipid peroxidation in kidney of vitamin B-6 deficient rats. Biochem Int 21 4 (1990) 599-605
34. Holmes R.P., and Assimos D.G. The impact of dietary oxalate on kidney stone formation. Urol Res 32 5 (2004) 311-316
35. Pak C.Y., Adams-Huet B., Poindexter J.R., et al. Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66 5 (2004) 2032-2037
36. Hoppe B., and Langman C.B. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 18 10 (2003) 986-991
37. Cochat P., Gaulier J.M., Koch Nogueira P.C., et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 158 Suppl 2 (1999) S75-S80
38. Milliner D.S., Wilson D.M., and Smith L.H. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int 59 1 (2001) 31-36
39. Rumsby G., Williams E., and Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 66 3 (2004) 959-963
40. Saborio P., and Scheinman J.I. Transplantation for primary hyperoxaluria in the United States. Kidney Int 56 3 (1999) 1094-1100
41. Dobbins J.W., and Binder H.J. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70 6 (1976) 1096-1100
42. Trus T.L., Pope G.D., and Finlayson S.R. National trends in utilization and outcomes of bariatric surgery. Surg Endosc 19 5 (2005) 616-620
43. Annuk M., Backman U., Holmgren K., et al. Urinary calculi and jejunoileal bypass operation. A long-term follow-up. Scand J Urol Nephrol 32 3 (1998) 177-180
44. Dhar N.B., Grundfest S., Jones J.S., et al. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation. J Urol 174 5 (2005) 1844-1846
45. Asplin J., and Coe F. Hyperoxaluria in bariatric surgery patients with urolithiasis. J Urol 175 Suppl (2006) 334-335
46. Nelson W.K., Houghton S.G., Milliner D.S., et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 1 5 (2005) 481-485
47. Traxer O., Huet B., Poindexter J., et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170 2 Pt 1 (2003) 397-401
48. Curhan G.C., Willett W.C., Rimm E.B., et al. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 155 6 (1996) 1847-1851
49. Curhan G.C., Willett W.C., Speizer F.E., et al. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 10 4 (1999) 840-845
50. Troxel S.A., Sidhu H., Kaul P., et al. Intestinal oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17 3 (2003) 173-176
51. Mikami K., Akakura K., Takei K., et al. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10 6 (2003) 293-296
52. Grover P.K., Marshall V.R., and Ryall R.L. Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol 10 3 (2003) 271-278
53. Grover P.K., and Ryall R.L. Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner Electrolyte Metab 20 6 (1994) 361-370
54. Pak C.Y., Holt K., and Zerwekh J.E. Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest Urol 17 2 (1979) 138-140
55. Levy F.L., Adams-Huet B., and Pak C.Y. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98 1 (1995) 50-59
56. Maalouf N.M., Cameron M.A., Moe O.W., et al. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13 2 (2004) 181-189
57. Hosking D.H., Erickson S.B., Van den Berg C.J., et al. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130 6 (1983) 1115-1118
58. Curhan G.C., Willett W.C., Rimm E.B., et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328 12 (1993) 833-838
59. Curhan G.C., Willett W.C., Speizer F.E., et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126 7 (1997) 497-504
60. Borghi L., Meschi T., Amato F., et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155 3 (1996) 839-843
61. Curhan G.C., Willett W.C., Rimm E.B., et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143 3 (1996) 240-247
62. Curhan G.C., Willett W.C., Speizer F.E., et al. Beverage use and risk for kidney stones in women. Ann Intern Med 128 7 (1998) 534-540
63. Wabner C.L., and Pak C.Y. Effect of orange juice consumption on urinary stone risk factors. J Urol 149 6 (1993) 1405-1408
64. Gettman M.T., Ogan K., Brinkley L.J., et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol 174 2 (2005) 590-594
65. Seltzer M.A., Low R.K., McDonald M., et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 156 3 (1996) 907-909
66. Goldfarb D.S., Fischer M.E., Keich Y., et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67 3 (2005) 1053-1061
67. Borghi L., Schianchi T., Meschi T., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346 2 (2002) 77-84
68. Fellstrom B., Danielson B.G., Karlstrom B., et al. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. Br J Urol 56 3 (1984) 263-269
69. Hiatt R.A., Ettinger B., Caan B., et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 144 1 (1996) 25-33
70. Heller H.J., Doerner M.F., Brinkley L.J., et al. Effect of dietary calcium on stone forming propensity. J Urol 169 2 (2003) 470-474
71. Pak C.Y., Heller H.J., Pearle M.S., et al. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 169 2 (2003) 465-469
72. Pak C.Y., Odvina C.V., Pearle M.S., et al. Effect of dietary modification on urinary stone risk factors. Kidney Int 68 5 (2005) 2264-2273
73. Krishnamurthy M.S., Hruska K.A., and Chandhoke P.S. The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 169 6 (2003) 2030-2033
74. Taylor E.N., Stampfer M.J., and Curhan G.C. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15 12 (2004) 3225-3232
75. Ohkawa M., Tokunaga S., Nakashima T., et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69 6 (1992) 571-576
76. Laerum E., and Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215 4 (1984) 383-389
77. Ettinger B., Citron J.T., Livermore B., et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139 4 (1988) 679-684
78. Wilson D.R., Strauss A.L., and Manuel M.A. Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol Res 12 (1984) 39
79. Pak C.Y., and Peterson R. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med 146 5 (1986) 863-867
80. Ettinger B., Tang A., Citron J.T., et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315 22 (1986) 1386-1389
81. Milliner D.S., Eickholt J.T., Bergstralh E.J., et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331 23 (1994) 1553-1558